Resources
Letter to the House Appropriations Subcommittee on Labor / HHS / Appropriations
PACH wrote a letter urging CMS to support a uniform set of quality measures, including those specific to cholesterol testing or management, where significant disparities exist.
Let’s Make Hypertension History
It’s time for innovation, access and awareness. Together, we can make hypertension history.
Racial Disparities Still Haunt Progress Against CVD
Cardiovascular disease stubbornly holds its place as the number one cause of death in America. But don’t be misled into thinking heart disease presents an equitable burden. It has a disproportionately high impact on Black Americans, striking them more often and more seriously, on average, than their white counterparts.
Blacks, Hispanics, and Women at Higher Risk of Being Denied Life-Saving Medication
Black, Hispanic, and women patients in Arkansas are more likely to face insurance barriers when trying to access a cholesterol-lowering heart medicine, according to a new report.
Hypertrophic Cardiomyopathy 101
Hypertrophic cardiomyopathy, or HCM, is a genetic disorder that occurs when the heart muscle thickens, making it harder to pump blood.
The Importance of PAD Screening
Anahita Dua, MD, explains that symptomless PAD can be a silent killer. That’s why screening, testing and education are critical for patients.
Fast Facts: Hypertrophic Cardiomyopathy
Many people with hypertrophic cardiomyopathy often go undiagnosed. This is because the symptoms of HCM aren’t always immediately recognized as indicators of a cardiac condition.
Position Statement: Hypertrophic Cardiomyopathy
Nearly one in every 250 people have HCM, but a large percentage of patients go undiagnosed because symptoms mimic other non-cardiac related diseases.
The Steps to a Hypertrophic Cardiomyopathy Diagnosis
Infographic
Early Detection is Key to Dealing with Peripheral Artery Disease
Peripheral artery disease, known as PAD, can cause serious health consequences. If left untreated, it can lead to a heart attack, a stroke or even amputation.
Mississippians Need Open Access to Life-Saving Cardiovascular Treatments
Nearly one-third of Mississippians live with high cholesterol,” cardiologist Dr. Kevin Hall writes, warning that insurance companies are statistically more likely to deny life-saving medications for Black and hispanic cardiovascular-disease patients, especially women.
Rejected: Patients Denied Access to Life-Saving Heart Medicine
When it comes to high cholesterol, access to the right medication could be a matter of life or death.